GMED Stock Overview
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for GMED from our risk checks.
My Notes
NewNotes are coming soon
Globus Medical, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$75.86 |
52 Week High | US$81.78 |
52 Week Low | US$52.60 |
Beta | 1.01 |
1 Month Change | 2.14% |
3 Month Change | 13.22% |
1 Year Change | 17.18% |
3 Year Change | 45.10% |
5 Year Change | 66.21% |
Change since IPO | 461.93% |
Recent News & Updates
Globus Medical: An Impressive Long-Term Revenue Growth Play
Jan 08Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
Dec 22Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends
Dec 01Recent updates
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
Dec 22Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends
Dec 01A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)
Oct 15Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around
Sep 02Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?
Aug 11Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital
May 24Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
May 06An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued
Mar 14Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest
Feb 24Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture
Feb 08Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?
Jan 21Are Globus Medical, Inc. (NYSE:GMED) Investors Paying Above The Intrinsic Value?
Nov 28Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture
Nov 10At US$76.32, Is Globus Medical, Inc. (NYSE:GMED) Worth Looking At Closely?
Oct 19Globus Medical (NYSE:GMED) Is Reinvesting At Lower Rates Of Return
Aug 07At US$78.13, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List?
Jul 20Calculating The Fair Value Of Globus Medical, Inc. (NYSE:GMED)
Jul 02It May Be Possible That Globus Medical, Inc.'s (NYSE:GMED) CEO Compensation Could Get Bumped Up
May 28Globus Medical (NYSE:GMED) Could Be Struggling To Allocate Capital
May 04Is It Time To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
Apr 13Globus Medical, Inc. (NYSE:GMED) Shares Could Be 34% Above Their Intrinsic Value Estimate
Mar 23Are Globus Medical, Inc.'s (NYSE:GMED) Mixed Financials Driving The Negative Sentiment?
Mar 05The Globus Medical (NYSE:GMED) Share Price Has Gained 190%, So Why Not Pay It Some Attention?
Feb 16Has Globus Medical (NYSE:GMED) Got What It Takes To Become A Multi-Bagger?
Jan 29Shareholder Returns
GMED | US Medical Equipment | US Market | |
---|---|---|---|
7D | 2.4% | -0.2% | 2.8% |
1Y | 17.2% | -9.7% | -9.2% |
Return vs Industry: GMED exceeded the US Medical Equipment industry which returned -9.7% over the past year.
Return vs Market: GMED exceeded the US Market which returned -9.2% over the past year.
Price Volatility
GMED volatility | |
---|---|
GMED Average Weekly Movement | 4.7% |
Medical Equipment Industry Average Movement | 8.8% |
Market Average Movement | 6.9% |
10% most volatile stocks in US Market | 17.3% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: GMED is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: GMED's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 2,400 | Dan Scavilla | https://www.globusmedical.com |
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.
Globus Medical, Inc. Fundamentals Summary
GMED fundamental statistics | |
---|---|
Market Cap | US$7.57b |
Earnings (TTM) | US$155.21m |
Revenue (TTM) | US$998.37m |
48.8x
P/E Ratio7.6x
P/S RatioIs GMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GMED income statement (TTM) | |
---|---|
Revenue | US$998.37m |
Cost of Revenue | US$254.93m |
Gross Profit | US$743.44m |
Other Expenses | US$588.23m |
Earnings | US$155.21m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 1.55 |
Gross Margin | 74.47% |
Net Profit Margin | 15.55% |
Debt/Equity Ratio | 0% |
How did GMED perform over the long term?
See historical performance and comparison